Unknown

Dataset Information

0

Glutathione S-transferase genes variants and glioma risk: A case-control and meta-analysis study.


ABSTRACT: Background: The glutathione S-transferase (GST) genes encode enzymes that metabolize carcinogenic compounds, and their variants, GSTP1 (Ile105Val and Ala114Val), GSTT1 (null/present), and GSTM1 (null/present), reduce enzyme activity that may affect the risk of developing cerebral glioma. This study undertook a case-control study and a meta-analysis to evaluate associations between these GST gene variants and the risk of glioma. Methods: The study enrolled 384 glioma patients (194 men and 190 women; mean age, 48.3 ± 9.2 years) and 340 healthy controls (174 men and 166 women; mean age, 46.5 ± 9.8 years). The amplification refractory mutation system assay was performed to identify GST gene variants of all 724 subjects. A meta-analysis enrolled 15 studies (including our case-control results) was performed. Results: Our case-control study found that the frequency of GSTP1 Ile105Val Val/Val genotype was significantly higher in the glioma group than that in the healthy controls (11.7% vs. 6.4%) (OR=1.50; 95% CI=1.05-2.04; P=0.01); the frequency of the Val/Ile + Ile/Ile genotypes was different from glioma patients and controls (88.3% vs. 93.6%) (OR=1.47(1.04-2.10); P=0.015); there were no associations between GSTP1 Ala114Val, GSTT1 (null/present) and GSTM1 (null/present) variants and glioma risk. Our meta-analysis confirmed that the GSTP1 Ile105Val variant was associated with an overall increased glioma risk. Moreover, our meta-analysis also confirmed the GSTP1 Ala114Val and GSTT1 null/present variants were associated with an increased glioma risk in the Caucasian population, rather than the Asian population. Conclusions: This study showed that GST gene variants were associated with an increased risk of glioma with ethnic differences. Future large-scale, multi center, controlled, prospective studies are required to support these findings and to determine how these GST gene variants may affect the pathogenesis of glioma.

SUBMITTER: Liu W 

PROVIDER: S-EPMC6746118 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Glutathione S-transferase genes variants and glioma risk: A case-control and meta-analysis study.

Liu Weiping W   Long Hongyu H   Zhang Mengqi M   Wang Yanjing Y   Lu Qiong Q   Yuan Haiyan H   Qu Qiang Q   Qu Jian J  

Journal of Cancer 20190819 19


<b>Background:</b> The glutathione S-transferase (GST) genes encode enzymes that metabolize carcinogenic compounds, and their variants, <i>GSTP1</i> (Ile105Val and Ala114Val), <i>GSTT1</i> (null/present)<i>,</i> and <i>GSTM1</i> (null/present)<i>,</i> reduce enzyme activity that may affect the risk of developing cerebral glioma. This study undertook a case-control study and a meta-analysis to evaluate associations between these GST gene variants and the risk of glioma. <b>Methods:</b> The study  ...[more]

Similar Datasets

| S-EPMC3416752 | biostudies-literature
| S-EPMC5407046 | biostudies-literature
| S-EPMC3559473 | biostudies-literature
| S-EPMC2654432 | biostudies-literature